Steris (STE) Total Non-Current Liabilities (2018 - 2026)
Steris (STE) posted Total Non-Current Liabilities of $3.4 billion for Q2 2026, down 0.83% on a QoQ basis from $3.5 billion in Q1 2026, and up 2.02% year-over-year from $3.4 billion in Q2 2025.
Analysis
Steris (STE) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Steris has reported Total Non-Current Liabilities for 9 years, with the latest figure at $3.4 billion in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 2.02% year-over-year to $3.4 billion in Q2 2026; TTM through Jun 2026 was $3.4 billion, a 2.02% increase from a year earlier, with the FY2026 full-year figure at $3.5 billion, changed 0.03% from the prior year.
- Total Non-Current Liabilities was $3.4 billion for Q2 2026 at Steris, down from $3.5 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $5.0 billion in Q3 2023, with the low at $3.3 billion in Q3 2025.
- Average Total Non-Current Liabilities over 5 years is $4.1 billion, with a median of $4.1 billion recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities soared 85.1% in 2022, then decreased 29.06% in 2024.
- Over 5 years, Total Non-Current Liabilities stood at $4.7 billion in 2022, then rose by 5.34% to $4.9 billion in 2023, then declined by 28.85% to $3.5 billion in 2024, then decreased by 4.29% to $3.4 billion in 2025, then increased by 2.49% to $3.4 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $3.4 billion (Q2 2026), $3.5 billion (Q1 2026), and $3.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.43 Bn | 177.83 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.55 Bn | 119.33 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.51 Bn | 102.03 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.23 Bn | 65.69 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.46 Bn | 45.21 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.87 Bn | 32.41 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.08 Bn | 30.13 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.05 Bn | 20.56 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.44 Bn |
| Mar 31, 2026 | 3.47 Bn |
| Dec 31, 2025 | 3.36 Bn |
| Sep 30, 2025 | 3.32 Bn |
| Jun 30, 2025 | 3.37 Bn |
| Mar 31, 2025 | 3.47 Bn |
| Dec 31, 2024 | 3.51 Bn |
| Sep 30, 2024 | 3.56 Bn |
| Jun 30, 2024 | 3.67 Bn |
| Mar 31, 2024 | 4.68 Bn |
| Dec 31, 2023 | 4.93 Bn |
| Sep 30, 2023 | 5.01 Bn |
| Jun 30, 2023 | 4.53 Bn |
| Mar 31, 2023 | 4.66 Bn |
| Dec 31, 2022 | 4.68 Bn |
| Sep 30, 2022 | 4.60 Bn |
| Jun 30, 2022 | 4.70 Bn |
| Mar 31, 2022 | 4.80 Bn |
| Dec 31, 2021 | 4.99 Bn |
| Sep 30, 2021 | 5.12 Bn |